Page last updated: 2024-10-29

ketoconazole and Depression, Involutional

ketoconazole has been researched along with Depression, Involutional in 5 studies

1-acetyl-4-(4-{[2-(2,4-dichlorophenyl)-2-(1H-imidazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy}phenyl)piperazine : A dioxolane that is 1,3-dioxolane which is substituted at positions 2, 2, and 4 by imidazol-1-ylmethyl, 2,4-dichlorophenyl, and [para-(4-acetylpiperazin-1-yl)phenoxy]methyl groups, respectively.

Depression, Involutional: Form of depression in those MIDDLE AGE with feelings of ANXIETY.

Research Excerpts

ExcerptRelevanceReference
" Part 1 was an open-label pharmacokinetic assessment of a single 5-mg vilazodone dose with or without ketoconazole."2.79Influence of CYP3A4 induction/inhibition on the pharmacokinetics of vilazodone in healthy subjects. ( Boinpally, R; Gad, N; Gupta, S; Periclou, A, 2014)
"Ketoconazole was generally well tolerated with no occurrence of significant side effects or laboratory abnormalities."2.69Antiglucocorticoid treatment of depression: double-blind ketoconazole. ( Canick, J; Chan, T; Johnson, R; Manfredi, F; Raum, W; Reus, VI; Wolkowitz, OM, 1999)
"Major depressive disorder affects a substantial percentage of the U."2.45Glucocorticoid inhibition in the treatment of depression: can we think outside the endocrine hypothalamus? ( Coleman, VH; Kling, MA; Schulkin, J, 2009)

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (40.00)18.2507
2000's1 (20.00)29.6817
2010's2 (40.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Boinpally, R1
Gad, N1
Gupta, S1
Periclou, A1
Kling, MA1
Coleman, VH1
Schulkin, J1
Paslakis, G1
Lecei, O1
Stalla, GK1
Landgraf, R1
Uhr, M1
Hamann, B1
Luppa, P1
Gilles, M1
Heuser, I1
Deuschle, M1
Wolkowitz, OM1
Reus, VI1
Chan, T1
Manfredi, F1
Raum, W1
Johnson, R1
Canick, J1
Bech, P1
Raabaek Olsen, L1
Jarløv, N1
Hammer, M1
Schütze, T1
Breum, L1

Reviews

1 review available for ketoconazole and Depression, Involutional

ArticleYear
Glucocorticoid inhibition in the treatment of depression: can we think outside the endocrine hypothalamus?
    Depression and anxiety, 2009, Volume: 26, Issue:7

    Topics: Adrenal Glands; Aminoglutethimide; Anti-Inflammatory Agents; Corticotropin-Releasing Hormone; Depres

2009

Trials

3 trials available for ketoconazole and Depression, Involutional

ArticleYear
Influence of CYP3A4 induction/inhibition on the pharmacokinetics of vilazodone in healthy subjects.
    Clinical therapeutics, 2014, Nov-01, Volume: 36, Issue:11

    Topics: Adolescent; Adult; Carbamazepine; Cross-Over Studies; Cytochrome P-450 CYP3A Inducers; Cytochrome P-

2014
The effect of treatment with ketoconazole on central CRH systems of depressed patients.
    Human psychopharmacology, 2011, Volume: 26, Issue:1

    Topics: 14-alpha Demethylase Inhibitors; Aged; Aged, 80 and over; Arginine Vasopressin; Corticotropin-Releas

2011
Antiglucocorticoid treatment of depression: double-blind ketoconazole.
    Biological psychiatry, 1999, Apr-15, Volume: 45, Issue:8

    Topics: Adult; Depressive Disorder, Major; Double-Blind Method; Female; Glucocorticoids; Humans; Hydrocortis

1999

Other Studies

1 other study available for ketoconazole and Depression, Involutional

ArticleYear
A case of sequential anti-stress medication in a patient with major depression resistant to amine-reuptake inhibitors.
    Acta psychiatrica Scandinavica, 1999, Volume: 100, Issue:1

    Topics: Amines; Antidepressive Agents; Anxiety Disorders; Dehydroepiandrosterone; Depressive Disorder, Major

1999